Construction of a novel 3-gene diagnostic signature related to senescence in intervertebral disc degeneration

构建与椎间盘退变衰老相关的新型3基因诊断特征

阅读:1

Abstract

BACKGROUND: Numerous studies have manifested that cellular senescence involves in the pathogenesis of intervertebral disc degeneration (IDD). Here, we constructed a novel senescence-related genes (SRGs) signature for IDD. METHODS: Three data sets were derived from Gene Expression Omnibus (GEO) database and 370 SRGs were collected from cellAge database. Key module genes related to senescence in IDD were screened using "WGCNA" package. The "limma" package was employed to filter differentially expressed genes (DEGs) between control and IDD groups, and candidate genes were identified by intersecting up-regulated DEGs and module genes. Hub genes were screened by randomForest and LASSO regression analysis. Diagnosis performance of hub genes was assessed and verified by receiver operating characteristic (ROC) curve. Diagnosis biomarkers of IDD were identified based on AUC > 0.7. Signaling pathway enrichment analysis of biomarkers was performed using "clusterProfiler" package. Immune cells infiltration was evaluated by "MCP-counter" and "GSVA" packages. RESULTS: A total of 625 module genes and 384 DEGs were obtained, then 28 candidate genes related to senescence in IDD were screened. By machine learning, 4 hub genes were identified with good diagnostic performance, which were highly expressed in IDD samples. Furthermore, 3 biomarkers (BID, KANK2, and SMIM3) were screened with AUC > 0.7 in external datasets. Three biomarkers were mainly involved in nuclear factor (NF)-kappa B, TNF, IL-17, and NOD-like receptor signaling pathway, etc. Besides, BID, KANK2, and SMIM3 exhibited positive association with most immune cell infiltration. CONCLUSIONS: We identified 3 diagnostic biomarkers related to senescence in IDD, hoping to improve the treatment of IDD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。